University of Florida researchers have developed a portable diagnostic device that detects and differentiates seven mosquito-borne viruses in under an hour, offering rapid results without the need for traditional lab equipment.
The new technologies address library normalization and amplification accuracy for high-throughput and oncology sequencing.
New additions to the COMET suite aim to improve flexibility and sensitivity in multiplex tissue analysis for research and preclinical development.
A novel reverse transcriptase is designed to offer a more complete view of the transcriptome by overcoming decades-old technical hurdles in sample preparation.
Read More
The French diagnostics company announced the clearance allows healthcare professionals to collect specimens by swabbing only the anterior part of the nasal cavity.
Read More
The program focuses on antibiotic resistance in urinary tract infections, with applications open until Nov 20.
Read More
The funding will support commercialization of the company’s extracellular vesicle-based liquid biopsy tests, starting with ovarian cancer screening.
Read More
The DNA-based stool screening test is now authorized for marketing through the MHRA, expanding access to non-invasive CRC detection.
Read More
A collaborative study has developed a low-cost, open-source, lyophilized RT-LAMP assay for pathogen detection.
Read More
Researchers have developed a CRISPR-Cas10-integrated graphene biosensor for amplification-free, ultra-sensitive RNA and miRNA detection.
Read More
Diasorin has launched the Simplexa C. auris Direct kit to aid in identifying Candida auris and enhance infection control.
Read More
A new study informed use of PARP inhibitors beyond BRCA1/2-deficient tumors and reevaluated biomarkers for PARP inhibition in prostate cancer.
Read More
The USPTO granted Sherlock Biosciences a patent for the diagnostic use of the Cas12 enzyme, establishing it as CRISPR diagnostics provider.
Read More
Researchers have developed a diagnostic method that can detect small amounts of cancer-related molecules in exosomes in plasma.
Read More
A new CRISPR protein discovery holds potential for the development of new inexpensive and highly sensitive at-home diagnostic tests.
Read More
Purigen Biosystems, Inc., has launched the Ionic Tissue to Pure DNA Kit, allowing users to extract increased yields of high-quality DNA.
Read More
Research shows that cell-free DNA in cerebrospinal fluid can be used to identify patients at risk of pediatric medulloblastoma relapse.
Read More
CRISPR technology may transform diagnostic capabilities by providing the sensitivity and flexibility of PCR tests but with increased speed and lower cost.
Read More